MAPT and Alzheimer disease: Our data also support the inference that the genetic and molecular underpinnings of tau deposition in Alzheimer’s disease may be distinct from established Alzheimer’s disease susceptibility genes, arguing for a broadening of thought regarding models of risk stratification and therapeutic targeting.